Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.1K Buy
83,454
+55,381
+197% +$33.1K ﹤0.01% 3424
2026
Q1
$17.7K Buy
+28,073
New +$21.1K ﹤0.01% 3496
2025
Q2
Sell
-47,544
Closed -$126K 3527
2025
Q1
$126K Sell
47,544
-394
-0.8% -$1.58K ﹤0.01% 3138
2024
Q4
$203K Buy
47,938
+17,721
+59% +$68.3K ﹤0.01% 2993
2024
Q3
$100K Sell
30,217
-9,424
-24% -$32K ﹤0.01% 3091
2024
Q2
$122K Sell
39,641
-1,761
-4% -$5.8K ﹤0.01% 2915
2024
Q1
$167K Buy
41,402
+3,196
+8% +$12.1K ﹤0.01% 2815
2023
Q4
$214K Buy
38,206
+6,062
+19% +$34.8K ﹤0.01% 2641
2023
Q3
$171K Buy
32,144
+16,038
+100% +$130K ﹤0.01% 2563
2023
Q2
$151K Sell
16,106
-2,677
-14% -$23.5K ﹤0.01% 2545
2023
Q1
$162K Sell
18,783
-210
-1% -$1.85K ﹤0.01% 2466
2022
Q4
$134K Buy
+18,993
New +$159K ﹤0.01% 2449

Other funds holding DCGO

Mariner's DCGO Position: Q2 2026 in Review

Mariner increased its DocGo (DCGO) stake by 197% in Q2 2026, buying an estimated $33.1K and bringing the position to 83,454 shares worth $43.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3424.

Mariner first reported a position in DCGO in Q4 2022 and has held it in 12 quarters since. The position peaked at $214K in Q4 2023. 119 funds tracked by Wall St. Rank hold DCGO as of Q2 2026.

  • Mariner held 83,454 shares of DocGo worth $43.1K as of Q2 2026.
  • Mariner bought 55,381 DocGo shares in Q2 2026, an estimated $33.1K.
  • DocGo made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3424 holding.
  • Mariner first reported a position in DocGo in Q4 2022 and has held it in 12 quarters since.
  • Mariner's DocGo position peaked at $214K in Q4 2023.
  • 119 funds tracked by Wall St. Rank held DocGo as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.